Replimune to resubmit twice-rejected drug for approval after FDA shakeup
Replimune was among the drugmakers that had criticized the FDA for what they called inconsistent guidance around trials and approvals
Why this matters for military families
Developments that affect daily life for service members and their families at duty stations worldwide.
Originally published by CNBC. Summary and curation by DutyStation.ai.
